Please enable JavaScript to continue using this application.

Compare $BMEA vs $CADL | Chartloom

Compare

$BMEA vs $CADL

Biomea Fusion Inc · Candel Therapeutics Inc

BMEA

Biomea Fusion Inc

CADL

Candel Therapeutics Inc

Compare $BMEA vs $CADL

Comparing Biomea Fusion Inc and Candel Therapeutics Inc

BMEABiomea Fusion Inc

CADLCandel Therapeutics Inc

BMEABiomea Fusion Inc

Market cap

$103M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

6.0%

52W performance

-15.5%

FCF yield

-46.0%

CADLCandel Therapeutics Inc

Market cap

$728M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

82.7%

52W performance

57.8%

FCF yield

-7.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BMEA

CADL

Detailed metrics comparison

BMEA

Biomea Fusion Inc

CADL

Candel Therapeutics Inc

Market Cap

BMEA$103M

CADL$728M

Enterprise Value

BMEA$68M

CADL$575M

Price

BMEA$1.42

CADL$9.94

P/E Ratio

BMEAN/A

CADLN/A

P/S Ratio

BMEA0.00x

CADL6,281.93x

EV/Sales

BMEA0.00x

CADL5,042.14x

EV/EBITDA

BMEA0.00x

CADL0.00x

P/B Ratio

BMEA7.58x

CADL6.18x

P/FCF Ratio

BMEAN/A

CADLN/A

EV/FCF

BMEA-1.44x

CADL-10.02x

PEG Ratio

BMEAN/A

CADLN/A

Forward P/E (NTM)

BMEAN/A

CADLN/A

Forward P/S (NTM)

BMEAN/A

CADLN/A

Revenue (TTM)

BMEA$0

CADL$0

Revenue Growth (YoY)

BMEAN/A

CADLN/A

Forward Rev Growth

BMEA-19.3%

CADL371.1%

Gross Margin (TTM)

BMEA0.0%

CADL0.0%

Operating Margin (TTM)

BMEA0.0%

CADL0.0%

EBITDA Margin (TTM)

BMEA0.0%

CADL0.0%

Net Margin (TTM)

BMEA0.0%

CADL0.0%

FCF Margin (TTM)

BMEAN/A

CADLN/A

Net Income (TTM)

BMEA$-33M

CADL$-89M

FCF (TTM)

BMEA$-47M

CADL$-57M

EPS (TTM)

BMEA-$0.45

CADL-$1.19

ROE (TTM)

BMEA-17119.0%

CADL-8938.0%

ROA (TTM)

BMEA-6606.0%

CADL-5631.0%

ROIC (TTM)

BMEA-17119.0%

CADL-6512.0%

Cash

BMEA$35M

CADL$202M

Debt

BMEA$0

CADL$48M

Net Cash/Debt

BMEA$35M

CADL$154M

Current Ratio (TTM)

BMEA3.48x

CADL16.09x

Quick Ratio (TTM)

BMEA3.36x

CADL15.89x

Debt/Equity (TTM)

BMEA0.00x

CADL0.38x

Debt/Assets (TTM)

BMEA0.0%

CADL0.0%

Interest Coverage (TTM)

BMEAN/A

CADLN/A

Net Debt/EBITDA (TTM)

BMEA0.00x

CADL0.00x

Beta

BMEA-0.24

CADL-0.28

52W Performance

BMEA-15.5%

CADL57.8%

YTD Performance

BMEA6.0%

CADL82.7%

% from 52W High

BMEA-36.5%

CADL-29.0%

% from 52W Low

BMEA62.9%

CADL128.5%

Asset Turnover (TTM)

BMEA0.00x

CADL0.00x

FCF Yield (TTM)

BMEA-46.0%

CADL-7.9%

Earnings Yield (TTM)

BMEA-31.7%

CADL-12.2%

Dividend Yield (TTM)

BMEAN/A

CADLN/A

Rule of 40

BMEA0.0

CADL0.0

EV/GP/RG

BMEAN/A

CADLN/A

Ticker research

View BMEA research View CADL research

Metric	BMEA Biomea Fusion Inc	CADL Candel Therapeutics Inc
Market & Valuation
Market Cap	$103M	$728M
Enterprise Value	$68M	$575M
Price	$1.42	$9.94
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	6,281.93x
EV/Sales	0.00x	5,042.14x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.58x	6.18x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.44x	-10.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-19.3%	371.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-89M
FCF (TTM)	$-47M	$-57M
EPS (TTM)	-$0.45	-$1.19
ROE (TTM)	-17119.0%	-8938.0%
ROA (TTM)	-6606.0%	-5631.0%
ROIC (TTM)	-17119.0%	-6512.0%
Financial Health
Cash	$35M	$202M
Debt	$0	$48M
Net Cash/Debt	$35M	$154M
Current Ratio (TTM)	3.48x	16.09x
Quick Ratio (TTM)	3.36x	15.89x
Debt/Equity (TTM)	0.00x	0.38x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.24	-0.28
52W Performance	-15.5%	57.8%
YTD Performance	6.0%	82.7%
% from 52W High	-36.5%	-29.0%
% from 52W Low	62.9%	128.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-46.0%	-7.9%
Earnings Yield (TTM)	-31.7%	-12.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BMEA research	View CADL research

Valuation

P/S Ratio

BMEA

0.00x

CADL

6,281.93x

EV/FCF

CADL

-10.02x

BMEA

-1.44x

Growth & revenue

Forward Revenue Growth

CADL

371.1%

BMEA

-19.3%

Profitability & performance

Gross Margin

BMEA

0.0%

CADL

0.0%

ROE

CADL

-8938.0%

BMEA

-17119.0%

FCF Yield %

CADL

-7.9%

BMEA

-46.0%

52-Week Performance

CADL

57.8%

BMEA

-15.5%

Detailed metrics comparison

BMEA

Biomea Fusion Inc

CADL

Candel Therapeutics Inc

Market Cap

BMEA$103M

CADL$728M

Enterprise Value

BMEA$68M

CADL$575M

Price

BMEA$1.42

CADL$9.94

P/E Ratio

BMEAN/A

CADLN/A

P/S Ratio

BMEA0.00x

CADL6,281.93x

EV/Sales

BMEA0.00x

CADL5,042.14x

EV/EBITDA

BMEA0.00x

CADL0.00x

P/B Ratio

BMEA7.58x

CADL6.18x

P/FCF Ratio

BMEAN/A

CADLN/A

EV/FCF

BMEA-1.44x

CADL-10.02x

PEG Ratio

BMEAN/A

CADLN/A

Forward P/E (NTM)

BMEAN/A

CADLN/A

Forward P/S (NTM)

BMEAN/A

CADLN/A

Revenue (TTM)

BMEA$0

CADL$0

Revenue Growth (YoY)

BMEAN/A

CADLN/A

Forward Rev Growth

BMEA-19.3%

CADL371.1%

Gross Margin (TTM)

BMEA0.0%

CADL0.0%

Operating Margin (TTM)

BMEA0.0%

CADL0.0%

EBITDA Margin (TTM)

BMEA0.0%

CADL0.0%

Net Margin (TTM)

BMEA0.0%

CADL0.0%

FCF Margin (TTM)

BMEAN/A

CADLN/A

Net Income (TTM)

BMEA$-33M

CADL$-89M

FCF (TTM)

BMEA$-47M

CADL$-57M

EPS (TTM)

BMEA-$0.45

CADL-$1.19

ROE (TTM)

BMEA-17119.0%

CADL-8938.0%

ROA (TTM)

BMEA-6606.0%

CADL-5631.0%

ROIC (TTM)

BMEA-17119.0%

CADL-6512.0%

Cash

BMEA$35M

CADL$202M

Debt

BMEA$0

CADL$48M

Net Cash/Debt

BMEA$35M

CADL$154M

Current Ratio (TTM)

BMEA3.48x

CADL16.09x

Quick Ratio (TTM)

BMEA3.36x

CADL15.89x

Debt/Equity (TTM)

BMEA0.00x

CADL0.38x

Debt/Assets (TTM)

BMEA0.0%

CADL0.0%

Interest Coverage (TTM)

BMEAN/A

CADLN/A

Net Debt/EBITDA (TTM)

BMEA0.00x

CADL0.00x

Beta

BMEA-0.24

CADL-0.28

52W Performance

BMEA-15.5%

CADL57.8%

YTD Performance

BMEA6.0%

CADL82.7%

% from 52W High

BMEA-36.5%

CADL-29.0%

% from 52W Low

BMEA62.9%

CADL128.5%

Asset Turnover (TTM)

BMEA0.00x

CADL0.00x

FCF Yield (TTM)

BMEA-46.0%

CADL-7.9%

Earnings Yield (TTM)

BMEA-31.7%

CADL-12.2%

Dividend Yield (TTM)

BMEAN/A

CADLN/A

Rule of 40

BMEA0.0

CADL0.0

EV/GP/RG

BMEAN/A

CADLN/A

Ticker research

View BMEA research View CADL research

Metric	BMEA Biomea Fusion Inc	CADL Candel Therapeutics Inc
Market & Valuation
Market Cap	$103M	$728M
Enterprise Value	$68M	$575M
Price	$1.42	$9.94
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	6,281.93x
EV/Sales	0.00x	5,042.14x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.58x	6.18x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.44x	-10.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-19.3%	371.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-89M
FCF (TTM)	$-47M	$-57M
EPS (TTM)	-$0.45	-$1.19
ROE (TTM)	-17119.0%	-8938.0%
ROA (TTM)	-6606.0%	-5631.0%
ROIC (TTM)	-17119.0%	-6512.0%
Financial Health
Cash	$35M	$202M
Debt	$0	$48M
Net Cash/Debt	$35M	$154M
Current Ratio (TTM)	3.48x	16.09x
Quick Ratio (TTM)	3.36x	15.89x
Debt/Equity (TTM)	0.00x	0.38x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.24	-0.28
52W Performance	-15.5%	57.8%
YTD Performance	6.0%	82.7%
% from 52W High	-36.5%	-29.0%
% from 52W Low	62.9%	128.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-46.0%	-7.9%
Earnings Yield (TTM)	-31.7%	-12.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BMEA research	View CADL research